A Usability Validation of the MuCopilot Mobile Application, a Digital Tool for the Unsupervised Objective Assessment of Cystic Fibrosis
- Sponsor
- Ad scientiam
- Study ID
- NCT06132048
- Status
- Recruiting
Conditions
- Cystic Fibrosis
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- MuCopilot mobile application — DEVICEMuCopilot is a software as medical device with three digital tests, to measure patient's with CF, lung function, global exercise capacity and a questionnaire to address CF symptoms and impacts on some aspects of patient's life
Study Details
The study aims to assess the usability and safety of use of MuCopilot, a smartphone application that measures objective data on lung function, global exercise capacity and patient reported outcomes of patients with Cystic Fibrosis (CF). These data are collected during unsupervised digital tests performed in the patient's home environment between consultations. The primary objective is to validate the usability and safety of use, in order to assure that the patients use the medical device as intended without any unacceptable error of use and without unacceptable risk. The study will include 17 CF patients and will be conducted in France. They will participate in 1 inclusion visit and 1 visit in-clinic (1h30). Patients will be able to download the free MuCopilot mobile application. During the visit, patients will complete 3 digital tests in order to monitor CF functions (cough, dyspnea \& walking) and 1 symptom questionnaire.
Key Dates
- First listed
- Nov 15, 2023
- Start date
- Jul 1, 2024
- Status verified
- Jan 2025
- Primary completion
- Jul 15, 2024
- Completion
- Feb 28, 2025
Study Design
- Enrollment
- 17 participants (estimated)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- OTHER
Arms
- Experimental: MuCopilot - Summative evaluationPerformance of digital tests and questionnaire from MuCopilot, during the visit.
Primary Outcome Measure
Validation of usability (1) [ Time Frame: 2 hours ]
Related Studies
- Role of Genetic Factors in the Development of Lung DiseaseRecruiting · National Heart, Lung, and Blood Institute (NHLBI) · Bethesda, Maryland
- Natural History of BronchiectasisRecruiting · National Heart, Lung, and Blood Institute (NHLBI) · Bethesda, Maryland
- Beta-cell Response to Incretin Hormones in Cystic FibrosisRecruiting · University of Pennsylvania · Philadelphia, Pennsylvania
- Genetics of Insulin and Incretins in Cystic FibrosisRecruiting · Children's Hospital of Philadelphia · Philadelphia, Pennsylvania